These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14760126)

  • 1. Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck.
    Aguilar-Ponce J; Granados-García M; Villavicencio V; Poitevin-Chacón A; Green D; Dueñas-González A; Herrera-Gómez A; Luna-Ortiz K; Alvarado A; Martínez-Said H; Castillo-Henkel C; Segura-Pacheco B; De la Garza J
    Ann Oncol; 2004 Feb; 15(2):301-6. PubMed ID: 14760126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
    Ali EM; Abdelraheem AG
    Head Neck Oncol; 2011 Nov; 3():48. PubMed ID: 22085617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent chemoradiation with low-dose and long-duration weekly infusion of gemcitabine in unresectable squamous cell carcinoma of head and neck (SCCHN).
    Ahmad F; Akram M; Khan M
    J Cancer Res Ther; 2024 Apr; 20(3):827-831. PubMed ID: 39023590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine, cisplatin, and radiation in advanced, unresectable squamous cell carcinoma of the head and neck: a feasibility study.
    Benasso M; Merlano M; Sanguineti G; Corvò R; Numico G; Ricci I; Pallestrini E; Santelli A; Vitale V; Marchetti G; Rosso R
    Am J Clin Oncol; 2001 Dec; 24(6):618-22. PubMed ID: 11801767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternating chemotherapy: gemcitabine and cisplatin with concurrent radiotherapy for treatment of advanced head and neck cancer.
    Aguilar-Ponce JL; Granados-García M; Cruz López JC; Maldonado-Magos F; Alvarez-Avitia MA; Arrieta O; González-Ramírez I; Lara-Cruz G; Martinez-Juárez I; Medina-Santillan R; Castillo-Hernández C; De la Garza-Salazar J
    Oral Oncol; 2013 Mar; 49(3):249-54. PubMed ID: 23043985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.
    Vanderveken OM; Szturz P; Specenier P; Merlano MC; Benasso M; Van Gestel D; Wouters K; Van Laer C; Van den Weyngaert D; Peeters M; Vermorken J
    Oncologist; 2016 Jan; 21(1):59-71. PubMed ID: 26712958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study.
    Halim AA; Wahba HA; El-Hadaad HA; Abo-Elyazeed A
    Med Oncol; 2012 Mar; 29(1):279-84. PubMed ID: 21279703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine concurrent with radiation therapy for locally advanced head and neck carcinomas.
    Chauhan A; Singh H; Sharma T; Manocha KK
    Afr Health Sci; 2008 Sep; 8(3):149-55. PubMed ID: 19357741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
    Zwitter M; Kovac V; Smrdel U; Strojan P
    J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma.
    de Castro G; Snitcovsky IM; Gebrim EM; Leitão GM; Nadalin W; Ferraz AR; Federico MH
    Eur Arch Otorhinolaryngol; 2007 Dec; 264(12):1475-82. PubMed ID: 17643256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I study.
    Mohiuddin M; Kudrimoti M; Regine WF; McGrath PC; Hanna N; John W
    Cancer J; 2002; 8(3):255-62. PubMed ID: 12074325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
    Specenier PM; Weyler J; Van Laer C; Van den Weyngaert D; Van den Brande J; Huizing MT; Altintas S; Vermorken JB
    BMC Cancer; 2009 Aug; 9():273. PubMed ID: 19660134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study.
    Jegannathen A; Mais K; Sykes A; Lee L; Yap B; Birzgalis A; Homer J; Ryder WD; Slevin N
    Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):149-58. PubMed ID: 20951012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.
    Milano MT; Haraf DJ; Stenson KM; Witt ME; Eng C; Mittal BB; Argiris A; Pelzer H; Kozloff MF; Vokes EE
    Clin Cancer Res; 2004 Aug; 10(15):4922-32. PubMed ID: 15297392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine-based induction chemotherapy and concurrent with radiation in advanced head and neck cancer.
    El Deen DA; Toson EA; El Morsy SM
    Med Oncol; 2012 Dec; 29(5):3367-73. PubMed ID: 22678924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study.
    Eisbruch A; Shewach DS; Bradford CR; Littles JF; Teknos TN; Chepeha DB; Marentette LJ; Terrell JE; Hogikyan ND; Dawson LA; Urba S; Wolf GT; Lawrence TS
    J Clin Oncol; 2001 Feb; 19(3):792-9. PubMed ID: 11157033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up data.
    Specenier PM; Van den Weyngaert D; Van Laer C; Weyler J; Van den Brande J; Huizing MT; Dyck J; Schrijvers D; Vermorken JB
    Ann Oncol; 2007 Nov; 18(11):1856-60. PubMed ID: 17823386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II trial of low-dose gemcitabine and radiation alternated to cisplatin and 5-fluorouracil: an active and manageable regimen for stage IV squamous cell carcinoma of the head and neck.
    Benasso M; Vigo V; Bacigalupo A; Ponzanelli A; Marcenaro M; Corvò R; Margarino G
    Radiother Oncol; 2008 Oct; 89(1):44-50. PubMed ID: 18423671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck.
    Hitt R; Castellano D; Hidalgo M; García-Carbonero R; Peña M; Brandariz A; Millán JM; Alvarez Vincent JJ; Cortés-Funes H
    Ann Oncol; 1998 Dec; 9(12):1347-9. PubMed ID: 9932167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil.
    Wibault P; Bensmaine MA; de Forni M; Armand JP; Tellez Bernal E; Guillot T; Recondo G; Domenge C; Janot F; Borel C; Luboinski B; Eschwege F; Cvitkovic E
    J Clin Oncol; 1996 Apr; 14(4):1192-200. PubMed ID: 8648374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.